Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics By: CNBC.com News November 01, 2022 at 16:09 PM EDT CEO Albert Bourla said Pfizer is staring down an expected loss of up to $18 billion in revenue from 2025 through 2030 as patent protections expire. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics By: CNBC.com News November 01, 2022 at 16:09 PM EDT CEO Albert Bourla said Pfizer is staring down an expected loss of up to $18 billion in revenue from 2025 through 2030 as patent protections expire. Read More >>